Keywords: tarceva, cleared, new, indication, japan, swiss, drug

Tarceva cleared for new indication in Japan

Article | 29 October 2007

Print This

Swiss drug major Roche's Tarceva (erlotinib) has been approved in Japan for the treatment of patients with nonresectable, recurrent and ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in